Professional Documents
Culture Documents
Sumber: https://www.covid19.go.id/
CORONA VIRUS INFECTIOUS DISEASE (COVID-19)
Coronaviruses are a family The virus is now known as
of viruses that can cause the severe acute
illnesses such as the respiratory syndrome
common cold, severe acute coronavirus 2 (SARS- CoV-
respiratory syndrome (SARS) 2). The disease it causes
and Middle East is called coronavirus
respiratory syndrome disease 2019 (COVID-19).
(MERS). In 2019, a new In March 2020, the World
coronavirus was identified Health Organization (WHO)
as the cause of a disease declared the COVID-19
outbreak that originated outbreak a pandemic.
in China.
https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963
MEKANISME PENULARAN VIRUS
GEJALA KLINIK
• Tiredness
• Aches
• Runny nose
• Sore throat
• Headache
• Diarrhea
• Vomiting
• Loss of smell
or taste
https://www.mayoclinic.org/covid-19-self-assessment-tool
TREATMENT
RISK COMPLICATIONS
CAUSES
FACTORS
https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963
LABORATORIUM COVID-19
LIMFOPENIA
MEKANISME LIMFOPENIA-SARS COV
APOPTOSIS
KELELAHAN
FUNGSIONAL
(NKG2A)
KAITAN
PASIEN
PEDIATRIK
HEMATOLOGI
N L R
The NLR was the Calculated
early automatically (band NLR is meaningful
identification of neutrophil + parameters for
risk factors for segmented prognosis and risk
2019-nCoV severe neutrophil)/ stratification
illness. Patients lymphocyte management, which
with age ≥ 50 and would be helpful to
NLR ≥ 3.13 alleviate
facilitated severe insufficient
illness and they medical resources.
should rapidly
access to
intensive care
unit if
necessary.
NLR SEBAGAI PENENTU TINDAKAN
RS Umum atau
Isolasi Mandiri
H F C
MENGGUNAKAN MENDETEKSI SEL MENGGAMBARKAN
METODE DENGAN TINGKAT ATIPIKAL
FLUORESENSI KEMATANGAN LIMFOSIT & SEL
DGN RESOLUSI RENDAH BLAST
TINGGI (EKSPRESI
DNA/RNA)
HEMATOLOGI
DIFF
Atypical scattergram
Lymp. &
Blast HFC IMG*
Monocyt Band
e
Lymphoc
Neu &
yte
Bas
Eosinop
NRBC hil
KOAGULASI
• Underlying disease
KRITERIA LAB MINIMAL DIC
1. Bukti adanya aktivasi koagulasi
a. Peningkatan prothrombin fragment 1,2
b. Peningkatan TAT (Thrombin-antitrombin complex)
c. Peningkatan fibrinopeptide A
d. Peningkatan D dimer
2. Bukti adanya aktivasi fibrinolysis
a. Peningkatan D dimer
b. peningkatan FDP
c. peningkatan plasmin dan
d. Plasmin-antiplasmin Complex (PAP)
3. Bukti adanya konsumsi inhibitor
4. Bukti adanya kerusakan end organ
MARI DIAM DI RUMAH!
https://www.covid19.go.id/download/gembira-dan-sehat-dengan-gizi-yang-seimbang/
Terima Kasih